An unusual about-face that played out at the FDA over the last week illustrated the power of the “Make America Healthy Again” ...

The US Food & Drug Administration's (FDA) resources have been cut more times than Martin Scorsese’s then-edgy 1988 religious ...

Whether in pill form or topical-foam form, the drug works the same way: “Minoxidil increases blood flow to hair follicles,” ...

For Dawn Steiner, 58, a speech pathologist, who participated in the clinical trial, the implant has been a game changer. She ...

Shares in cancer drug developer Syntara (ASX:SNT) this morning lost almost half their value, after unfavourable advice from ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) has officially entered the most critical phase of its development ...

In this video interview, Meri Beckwith, Co-CEO of Lindus Health, explains why sponsors pursuing breakthrough or priority ...

The rising bladder cancer star that is the combination of Pfizer and Astellas’ Padcev and Merck’s Keytruda is looking to set ...

Jason Bergsbaken, PharmD, MBA, BCOP, highlights the growing role of real-world data in validating or de-implementing therapies, the need for vigilant postapproval outcomes monitoring, and the value of ...